At3g05180 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate-Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At3g05180 antibody; T12H1.15GDSL esterase/lipase At3g05180 antibody; EC 3.1.1.- antibody; Extracellular lipase At3g05180 antibody
Target Names
At3g05180
Uniprot No.

Target Background

Database Links

KEGG: ath:AT3G05180

STRING: 3702.AT3G05180.1

UniGene: At.18376

Protein Families
'GDSL' lipolytic enzyme family
Subcellular Location
Secreted.

Q&A

What is the At3g05180 antibody and what protein does it target?

The At3g05180 antibody targets the protein encoded by the At3g05180 gene in Arabidopsis thaliana. This gene encodes a protein involved in cellular processes that has been studied in plant immunology research. Detection of this protein requires specific antibodies designed to recognize unique epitopes on the protein structure. Effective antibody design relies on thorough characterization of the target protein's structure, accessibility of epitopes, and potential cross-reactivity with related proteins. The development of such antibodies follows standardized immunization protocols and validation procedures to ensure specificity and sensitivity in experimental applications .

What are the optimal validation methods for confirming At3g05180 antibody specificity?

Validation of At3g05180 antibody specificity should employ multiple complementary approaches:

  • Western blot analysis using both wild-type and knockout/knockdown plant tissues

  • Immunoprecipitation followed by mass spectrometry identification

  • Immunohistochemical staining with appropriate negative controls

  • Pre-absorption tests with purified antigen

  • Cross-reactivity assessment with related Arabidopsis proteins
    A comprehensive validation approach requires testing against tissues with varying expression levels of the target protein. Researchers should confirm antibody binding characteristics including binding site locations and affinity values (KD), which can be experimentally determined using methods similar to those described for other antibody systems . A proper validation protocol ensures that experimental results reflect true biological phenomena rather than artifacts of non-specific binding.

How should I optimize immunoblotting protocols for At3g05180 detection?

Optimization of immunoblotting for At3g05180 detection requires systematic testing of multiple parameters:

ParameterRecommended RangeOptimization Tips
Protein Loading10-50 μg total proteinTitrate to determine minimal amount needed for detection
Blocking Solution3-5% BSA or non-fat milkTest both to determine which gives lower background
Primary Antibody Dilution1:500-1:5000Perform dilution series to balance signal and background
Incubation Time1-16 hoursLonger at 4°C may improve sensitivity
Washing BufferTBS-T (0.05-0.1% Tween-20)More stringent washing for high background
Secondary AntibodyHRP or fluorescently-labeledMatch to detection system availability
Detection MethodChemiluminescence or fluorescenceChoose based on required sensitivity
When optimizing these protocols, researchers should systematically vary one parameter at a time while keeping others constant. This methodical approach ensures identification of the optimal conditions for specific and sensitive detection of the At3g05180 protein .

How can I determine the binding affinity of the At3g05180 antibody?

Determining binding affinity of the At3g05180 antibody requires quantitative measurement of antibody-antigen interactions. This can be accomplished through:

  • Surface Plasmon Resonance (SPR) using purified At3g05180 protein

  • Bio-Layer Interferometry (BLI) for real-time binding kinetics

  • Enzyme-Linked Immunosorbent Assay (ELISA) with serial dilutions

  • Flow cytometry-based measurements with expressing cells
    The binding affinity (KD) can be calculated using models similar to those described for other antibody systems. For example, a statistical-physics-based theoretical model can be applied to analyze binding data and extract affinity parameters . When performing these analyses, it's essential to account for potential non-specific binding and ensure that the experimental setup mimics physiological conditions as closely as possible.

What controls should be included in immunoprecipitation experiments using At3g05180 antibody?

Rigorous immunoprecipitation experiments with At3g05180 antibody should include these essential controls:

  • Input sample (pre-immunoprecipitation lysate)

  • No-antibody control (beads only)

  • Isotype control antibody (irrelevant antibody of same isotype)

  • Pre-immune serum control (for polyclonal antibodies)

  • Competitive peptide blocking control

  • Tissue or cells lacking At3g05180 expression (knockout/knockdown)
    Each control serves to identify potential sources of experimental artifacts. The input sample confirms target protein presence in starting material, while no-antibody and isotype controls detect non-specific binding to beads or constant regions. Competitive peptide blocking demonstrates binding specificity, and knockout controls verify antibody specificity. Together, these controls enable confident interpretation of immunoprecipitation results .

How can I optimize fixation methods for immunohistochemistry with At3g05180 antibody?

Optimization of fixation for immunohistochemistry depends on epitope sensitivity to fixatives:

Fixation MethodMechanismAdvantagesDisadvantagesBest For
4% ParaformaldehydeCrosslinks proteinsGood morphology, moderate epitope preservationMay mask some epitopesMost applications
AcetonePrecipitates proteins, removes lipidsMinimal epitope masking, quickPoor morphology preservationMembrane proteins
MethanolPrecipitates proteins, removes lipidsGood for cytoskeletal proteinsCan denature some epitopesNuclear proteins
GlutaraldehydeStrong crosslinkingExcellent ultrastructureSignificant epitope maskingElectron microscopy
Heat-induced epitope retrievalReverses fixation crosslinksRecovers masked epitopesMay damage tissueOver-fixed tissues
For At3g05180 detection, researchers should systematically test different fixation methods and durations to determine which best preserves the specific epitope recognized by the antibody while maintaining adequate tissue morphology. Antigen retrieval methods may also be necessary depending on the fixative used and should be optimized alongside fixation protocols .

How should quantitative analysis of At3g05180 immunofluorescence be performed?

Quantitative analysis of At3g05180 immunofluorescence requires:

  • Image acquisition with consistent exposure settings

  • Background subtraction using appropriate controls

  • Segmentation of cellular compartments (if analyzing subcellular localization)

  • Normalization to account for variation in staining efficiency

  • Statistical analysis of fluorescence intensity across samples
    When quantifying immunofluorescence signals, researchers should analyze multiple fields of view across biological replicates. Image analysis software such as ImageJ/FIJI with appropriate plugins can be used to segment cells and quantify signal intensities. For colocalization studies, proper statistical methods like Pearson's correlation coefficient or Manders' overlap coefficient should be employed to quantify the degree of spatial correlation between At3g05180 and other cellular components .

How can I distinguish between specific and non-specific binding in At3g05180 immunoblots?

Distinguishing specific from non-specific binding requires:

  • Comparison with predicted molecular weight of At3g05180 protein

  • Analysis of band pattern in wild-type vs. knockout/knockdown samples

  • Competition assays with purified antigen

  • Evaluation of positive and negative control tissues

  • Correlation of band intensity with known expression levels across tissues
    Non-specific binding typically presents as multiple bands that appear in both experimental and control samples. Specific binding should show a band of expected molecular weight that is absent or reduced in knockout/knockdown samples and can be blocked by pre-incubation with the immunizing peptide. Researchers should also consider post-translational modifications that may alter the apparent molecular weight of the target protein .

How can competitive binding models be applied to evaluate At3g05180 antibody interactions?

Competitive binding models can provide valuable insights into At3g05180 antibody interactions:
The application of statistical-physics-based theoretical models, similar to those described for other antibody systems, can be used to analyze the interaction between At3g05180 antibodies and their target protein. Such models incorporate parameters including:

  • Number of binding sites on the protein (N)

  • Number of sites an antibody covers when bound (λ)

  • Site-specific and fragment-specific affinity values (Ks,l(i))

  • Antibody concentration (cs)
    These parameters can be experimentally determined and used to predict binding behavior under different conditions. This approach allows researchers to optimize experimental conditions and interpret complex binding data in systems where multiple antibody clones may compete for binding sites .

What approaches can be used to improve At3g05180 antibody specificity for challenging applications?

Improving antibody specificity for challenging applications involves:

  • Affinity purification against immobilized antigen

  • Negative selection against cross-reactive proteins

  • Epitope-specific purification using peptide affinity columns

  • Fragment preparation (Fab, F(ab')2) to reduce non-specific binding via Fc

  • Pre-adsorption against tissues lacking the target protein
    For critical applications requiring exceptional specificity, researchers can implement a multi-step purification process. This might include initial purification on protein A/G followed by antigen-specific affinity chromatography and negative selection steps. Validation of the purified antibody should be performed in the specific experimental context where it will be used, as specificity can vary between applications .

How can I develop quantitative assays for measuring At3g05180 protein levels in plant tissues?

Development of quantitative assays requires:

Assay TypePrincipleAdvantagesLimitationsKey Optimization Steps
Quantitative Western BlotDensitometry of immunoblot bandsSimple equipment, widely accessibleNarrow dynamic rangeStandard curve with purified protein
ELISAAntibody sandwich assayHigh throughput, good sensitivityRequires pair of antibodiesOptimization of antibody concentrations
AlphaLISABead-based proximity assayNo wash steps, high sensitivitySpecialized equipment neededDonor/acceptor bead ratio
Mass SpectrometryPeptide quantificationAbsolute quantification possibleComplex sample preparationSelection of appropriate peptides
Flow CytometrySingle-cell antibody bindingCell-to-cell variability dataRequires cell suspensionPermeabilization optimization
When developing quantitative assays, researchers must generate standard curves using known quantities of purified At3g05180 protein or synthetic peptides. Method validation should include assessment of linearity, reproducibility, lower limit of detection, and potential matrix effects from plant tissue components .

What strategies can address epitope masking or conformational changes affecting At3g05180 antibody recognition?

Addressing epitope accessibility issues requires:

  • Testing multiple antibodies targeting different epitopes

  • Exploring various antigen retrieval methods (heat, pH, enzymatic)

  • Adjusting extraction conditions to preserve native protein conformation

  • Using denaturing conditions to expose linear epitopes

  • Employing mild detergents to improve accessibility of membrane-associated epitopes
    Researchers should consider the biological context of the At3g05180 protein and potential interactions with other cellular components that might mask epitopes. For example, if the protein forms complexes or undergoes conformational changes in response to cellular signals, antibody recognition might be affected. Epitope mapping can help identify accessible regions under different experimental conditions .

How can I address weak or absent signal when using At3g05180 antibody?

Addressing weak or absent signals requires systematic troubleshooting:

  • Verify target protein expression in the sample

  • Increase antibody concentration or incubation time

  • Test different detection systems with higher sensitivity

  • Optimize protein extraction to improve target protein solubility

  • Try different blocking agents to reduce non-specific binding

  • Consider epitope retrieval methods for fixed samples

  • Verify antibody functionality with positive control samples
    Researchers should maintain detailed records of optimization efforts. A methodical approach to varying one parameter at a time helps identify the limiting factor. In some cases, the epitope may be inaccessible due to protein folding or post-translational modifications, requiring alternative antibodies or epitope retrieval methods .

What approaches can resolve high background when using At3g05180 antibody?

Resolving high background issues involves:

  • Increasing blocking stringency (higher concentration or different blocking agent)

  • Adding carrier proteins (BSA, non-fat milk) to antibody dilutions

  • Increasing wash duration and stringency

  • Reducing primary and secondary antibody concentrations

  • Pre-adsorbing antibody against tissues lacking the target protein

  • Using more specific detection methods

  • Considering alternative secondary antibodies
    High background often results from non-specific binding to abundant plant proteins or from cross-reactivity. Optimizing the ratio of specific to non-specific binding is critical for obtaining interpretable results. Additional purification of the primary antibody or using F(ab')2 fragments instead of whole IgG may help reduce background in challenging samples .

How can At3g05180 antibody be adapted for super-resolution microscopy applications?

Adapting antibodies for super-resolution microscopy requires:

  • Selection of bright, photostable fluorophores appropriate for the chosen technique

  • Optimization of labeling density to match resolution requirements

  • Evaluation of antibody penetration in fixed specimens

  • Use of smaller detection reagents (Fab fragments, nanobodies)

  • Development of specific sample preparation protocols
    For techniques like STORM and PALM, researchers should consider direct conjugation of photoswitchable fluorophores to the primary antibody. For STED microscopy, fluorophores with appropriate depletion characteristics should be selected. In all cases, sample preparation must be optimized to minimize background fluorescence while maintaining structural integrity and epitope accessibility .

What considerations are important when designing multiplex immunoassays including At3g05180 detection?

Designing multiplex immunoassays requires careful planning:

  • Selection of antibodies with compatible species origins or isotypes

  • Verification of non-cross-reactivity between detection systems

  • Optimization of antibody concentrations for balanced signals

  • Selection of fluorophores with minimal spectral overlap

  • Sequential staining protocols for antibodies with potential interference

  • Appropriate controls for each target in the multiplex panel
    When developing multiplex assays, researchers should first validate each antibody individually and then in combination. Cross-blocking experiments can identify potential interference between antibodies. Specialized techniques such as tyramide signal amplification may help balance signals from targets with different expression levels. Careful selection of filter sets and image acquisition parameters is essential for accurate signal separation .

How can computational modeling help predict At3g05180 antibody binding characteristics?

Computational modeling provides valuable insights:
The application of biophysical models can help predict antibody binding behavior under various conditions. Similar to the approach described for other antibody systems, researchers can develop mathematical frameworks that incorporate:

  • Protein structure and epitope accessibility

  • Antibody binding kinetics and thermodynamics

  • Competitive binding effects

  • Concentration dependencies
    These models can be experimentally validated and then used to simulate binding under various experimental conditions. This approach allows researchers to optimize experimental design and interpret complex binding data, particularly in scenarios where multiple factors may influence antibody recognition. Such models can be computationally efficient and implemented in software packages for wider accessibility .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.